Document Preview Unavailable

Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells

Zhou, Chen; Shen, Guowen; Yang, Fan; Duan, Jingling; Wu, Zhen; et al.  Journal of Cellular and Molecular Medicine (Online) Vol. 24, Iss. 11,  (Jun 1, 2020): 6438-6447.

You might have access to this document